Healthcare -
Biotechnology - NASDAQ - US
$ 4.585
-1.98 %
$ 282 M
Market Cap
-4.55
P/E
GLUE - CAPITAL EXPENDITURES
Capital Expenditures GLUE - Monte Rosa Therapeutics, Inc.
-3.99 M
LAST VALUE
44.42%
2 YEAR CAGR
-23.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR